CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 186 filers reported holding CYTOKINETICS INC in Q3 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,292,214 | -17.4% | 315,418 | -8.6% | 0.00% | -25.0% |
| Q2 2023 | $11,256,119 | -20.3% | 345,068 | -14.0% | 0.00% | -20.0% |
| Q1 2023 | $14,116,620 | -26.2% | 401,154 | -3.9% | 0.01% | -28.6% |
| Q4 2022 | $19,125,000 | -27.3% | 417,392 | -23.1% | 0.01% | -30.0% |
| Q3 2022 | $26,304,000 | +19.2% | 542,896 | -3.3% | 0.01% | +25.0% |
| Q2 2022 | $22,058,000 | +7.2% | 561,342 | +0.4% | 0.01% | +33.3% |
| Q1 2022 | $20,575,000 | -19.3% | 558,970 | -0.1% | 0.01% | -14.3% |
| Q4 2021 | $25,506,000 | +101.9% | 559,582 | +58.3% | 0.01% | +75.0% |
| Q3 2021 | $12,633,000 | +102.6% | 353,435 | +12.2% | 0.00% | +100.0% |
| Q2 2021 | $6,235,000 | -15.2% | 315,022 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $7,352,000 | +17.5% | 316,029 | +4.9% | 0.00% | 0.0% |
| Q4 2020 | $6,259,000 | -7.5% | 301,176 | -3.7% | 0.00% | -33.3% |
| Q3 2020 | $6,767,000 | +4.2% | 312,623 | +13.5% | 0.00% | 0.0% |
| Q2 2020 | $6,495,000 | +78.5% | 275,560 | -10.7% | 0.00% | +50.0% |
| Q1 2020 | $3,639,000 | +6.6% | 308,645 | -4.1% | 0.00% | +100.0% |
| Q4 2019 | $3,413,000 | -5.7% | 321,749 | +1.2% | 0.00% | -50.0% |
| Q3 2019 | $3,619,000 | -0.3% | 318,035 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $3,629,000 | +44.1% | 322,560 | +3.6% | 0.00% | +100.0% |
| Q1 2019 | $2,519,000 | +30.5% | 311,350 | +2.0% | 0.00% | 0.0% |
| Q4 2018 | $1,930,000 | -37.4% | 305,385 | -2.4% | 0.00% | 0.0% |
| Q3 2018 | $3,083,000 | +31.5% | 312,951 | +10.8% | 0.00% | 0.0% |
| Q2 2018 | $2,344,000 | +23.5% | 282,340 | +7.1% | 0.00% | 0.0% |
| Q1 2018 | $1,898,000 | -9.4% | 263,590 | +2.5% | 0.00% | 0.0% |
| Q4 2017 | $2,096,000 | -59.7% | 257,236 | -28.3% | 0.00% | -50.0% |
| Q3 2017 | $5,201,000 | +78.5% | 358,713 | +48.9% | 0.00% | +100.0% |
| Q2 2017 | $2,914,000 | +126.1% | 240,831 | +31.8% | 0.00% | 0.0% |
| Q1 2016 | $1,289,000 | -36.5% | 182,791 | -5.9% | 0.00% | 0.0% |
| Q4 2015 | $2,031,000 | +1746.4% | 194,179 | +1086.6% | 0.00% | – |
| Q2 2015 | $110,000 | +5400.0% | 16,365 | +2237.9% | 0.00% | – |
| Q3 2014 | $2,000 | -33.3% | 700 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | -76.9% | 700 | -57.7% | 0.00% | – |
| Q3 2013 | $13,000 | -27.8% | 1,654 | +7.1% | 0.00% | – |
| Q2 2013 | $18,000 | – | 1,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |